Viewing Study NCT06700369


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-02-20 @ 6:25 PM
Study NCT ID: NCT06700369
Status: RECRUITING
Last Update Posted: 2024-11-25
First Post: 2024-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients
Sponsor: Shu Wang
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neoadjuvant chemotherapy View
None De-escalation View